logo
episode-header-image
Oct 2025
37m 17s

Marriage and Sex in the Age of Ozempic

The New York Times
About this episode
In the last few years, GLP-1 weight-loss drugs like Ozempic and Zepbound have been radically reshaping the people’s lives, changing appetites and health. But the drugs also have the power to affect other parts of consumers’ lives, including their romantic relationships. Lisa Miller, who writes about health for The New York Times, tells the story of how the ... Show More
Up next
Yesterday
Keisha Lance Bottoms on What Democrats Have to Do to Not Squander the Win
The governor-elect of Georgia is elated about her party’s victories in the South, but knows realignment is far from secure.Thoughts? Email us at theinterview@nytimes.comWatch our show on YouTube: youtube.com/@TheInterviewPodcastFor transcripts and more, visit: nytimes.com/theinte ... Show More
30m 6s
Nov 7
Introducing ‘METRO’ From Serial Productions
Today, we’re sharing an episode from a brand-new show called “METRO,” made by the Serial podcast team and the reporters here at The Times who cover New York City.Every other week, Sarah Koenig and her team will tell stories about the city and its most fascinating raw material: Ne ... Show More
41m 42s
Nov 6
Chuck Schumer on Governing With (Or Without) Trump
Warning: This episode contains strong language.Last spring, the political picture for Senator Chuck Schumer, the minority leader, was downright bleak. President Trump was back in the White House. Schumer’s Democratic caucus was largely powerless to stop him. And restless Democrat ... Show More
34m 29s
Recommended Episodes
Jul 2023
One Thing: Weight Loss Drugs: Trend or Treatment?
A new group of drugs for type 2 diabetes and obesity have shown to be more effective for weight loss than any previous medications. Some medications like Ozempic and Wegovy have surged in popularity thanks in part to celebrity use. But who should be taking them? And are they safe ... Show More
17m 14s
Sep 2023
After Ozempic
Ozempic and other drugs like it are being heralded as game changers for weight loss. Radio Atlantic host Hanna Rosin talks to Atlantic staff writer Olga Khazan about what it means that this medical intervention has arrived at a time when our society seems to be easing away from f ... Show More
24m 15s
Dec 2024
A checkup on weight-loss drugs
What started as a story about Hollywood waistlines has become a global phenomenon. Weight loss drugs are becoming more and more mainstream a few years after making their dramatic debut. On this weekend episode of Reuters World News, our health reporters weigh in on the impact of ... Show More
20m 17s
May 2024
The Ozempic Obsession with Jia Tolentino
<p>Ozempic. It started with a lizard, and then transformed into a drug that, depending on who you ask, is either a miracle or the downfall of society. New Yorker writer and cultural critic Jia Tolentino joins Trevor and Christiana to give context on the media circus surrounding w ... Show More
48m 29s
May 2024
The world after Ozempic
Ozempic and other new weight loss drugs are being touted as potential miracle cures for diabetes and obesity. Journalist Johann Hari experimented with the drug and dropped 40 pounds. In his new book, Magic Pill, Hari discusses his experience with Ozempic and speaks to many of the ... Show More
50m 53s
Dec 2024
068 | The weight is over: How GLP-1 treatments are reshaping pharma and beyond
Weight-loss drugs have become a golden formula for pharma growth. In this episode we speak to Sector Advisor Maria Latorre and Senior Economist Michaela Grimm about how GLP-1 treatments like Ozempic and Wegovy are reshaping the industry, and the risks that lie ahead. SHOWNOTES: • ... Show More
11m 16s
Jul 2023
How Drugs Like Ozempic Are Changing What We Think About Weight Loss
You may have heard about Ozempic, Wegovy and Mounjaro. It’s tough to miss the online chatter, the ads on TV and all the news coverage. They are part of a class of drugs originally designed to treat diabetes, and all three have been shown to help people lose significant amounts of ... Show More
28m 5s